Matches in SemOpenAlex for { <https://semopenalex.org/work/W3029465454> ?p ?o ?g. }
Showing items 1 to 96 of
96
with 100 items per page.
- W3029465454 endingPage "1450" @default.
- W3029465454 startingPage "1448" @default.
- W3029465454 abstract "ObjectiveTo study the effect of triptolide combined with cisplatin on immune function and angiogenesis of bladder cancer (T24) cells-bearing nude mice.MethodsEighteen bladder cancer (T24) cells-bearing nude mice were divided into control group, cisplatin group, and combination group, respectively given intraperitoneal injection of 0.9% sodium chloride solution, cisplatin, and triptolide+ cisplatin. Flow cytometry was used to detect fluoresceine isothiocyanate (FITC)-dexran positive rate of abdominal macrophages, enzyme linked immunosorbent assay (ELISA) to determine interleukin (IL)-1 and tumor necrosis factor-α (TNF-α) expression levels in the abdominal macrophages, and immunohistochemical staining to examine vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and microvessel density (MVD) expression levels.ResultsThe positive rate of FITC-dexran, CD11b-FITC, and CD68-FITC in abdominal macrophages of combination group was significantly higher than that in cisplatin group [(11.74±1.25)% vs. (7.24±0.84)%, (33.33±3.46)% vs. (21.84±2.45)%, and (33.89±4.12)% vs. (20.52±2.32)%] (t=9.639-7.319, P<0.05). The IL-1 and TNF-α expression levels in combination group were significantly higher than those in cisplatin group [(40.92±3.86) vs. (26.05±3.01) pg/ml, and (55.78±6.25) vs. (38.42±5.26) pg/ml] (t=5.201-7.441, P<0.05). The VEGF, bFGF, and MVD expression levels in combination group were significantly lower than those in cisplatin group (1.24±0.48 vs. 1.88±0.52, 0.88±0.43 vs. 1.51±0.56, and 3.11±1.49 vs. 8.15±3.00) (t=2.186-3.686, P<0.05).ConclusionTriptolide combined with cisplatin can improve phagocytosis function and immune function of abdominal macrophages in bladder cancer (T24) cells-bearing nude mice, and reduce VEGF and bFGF expression levels, and then inhibit growth and proliferation of tumor cells.Key words: Urinary bladder neoplasms; Triptolide; Cisplatin; Immune function; Vascular growth factors" @default.
- W3029465454 created "2020-06-05" @default.
- W3029465454 creator A5018244700 @default.
- W3029465454 creator A5050965079 @default.
- W3029465454 creator A5076726899 @default.
- W3029465454 creator A5078725248 @default.
- W3029465454 date "2016-06-08" @default.
- W3029465454 modified "2023-09-23" @default.
- W3029465454 title "Effect of triptolide combined with cisplatin on immune function and angiogenesis of bladder cancer (T24) cells-bearing nude mice" @default.
- W3029465454 doi "https://doi.org/10.3760/cma.j.issn.1001-9030.2016.06.004" @default.
- W3029465454 hasPublicationYear "2016" @default.
- W3029465454 type Work @default.
- W3029465454 sameAs 3029465454 @default.
- W3029465454 citedByCount "0" @default.
- W3029465454 crossrefType "journal-article" @default.
- W3029465454 hasAuthorship W3029465454A5018244700 @default.
- W3029465454 hasAuthorship W3029465454A5050965079 @default.
- W3029465454 hasAuthorship W3029465454A5076726899 @default.
- W3029465454 hasAuthorship W3029465454A5078725248 @default.
- W3029465454 hasConcept C121332964 @default.
- W3029465454 hasConcept C121608353 @default.
- W3029465454 hasConcept C126322002 @default.
- W3029465454 hasConcept C167734588 @default.
- W3029465454 hasConcept C170493617 @default.
- W3029465454 hasConcept C17991360 @default.
- W3029465454 hasConcept C185592680 @default.
- W3029465454 hasConcept C190283241 @default.
- W3029465454 hasConcept C2775960820 @default.
- W3029465454 hasConcept C2776694085 @default.
- W3029465454 hasConcept C2777019933 @default.
- W3029465454 hasConcept C2777025900 @default.
- W3029465454 hasConcept C2777587049 @default.
- W3029465454 hasConcept C2778239845 @default.
- W3029465454 hasConcept C2778939058 @default.
- W3029465454 hasConcept C2780159080 @default.
- W3029465454 hasConcept C2780352672 @default.
- W3029465454 hasConcept C2780394083 @default.
- W3029465454 hasConcept C2781164371 @default.
- W3029465454 hasConcept C55493867 @default.
- W3029465454 hasConcept C62520636 @default.
- W3029465454 hasConcept C71924100 @default.
- W3029465454 hasConcept C91881484 @default.
- W3029465454 hasConceptScore W3029465454C121332964 @default.
- W3029465454 hasConceptScore W3029465454C121608353 @default.
- W3029465454 hasConceptScore W3029465454C126322002 @default.
- W3029465454 hasConceptScore W3029465454C167734588 @default.
- W3029465454 hasConceptScore W3029465454C170493617 @default.
- W3029465454 hasConceptScore W3029465454C17991360 @default.
- W3029465454 hasConceptScore W3029465454C185592680 @default.
- W3029465454 hasConceptScore W3029465454C190283241 @default.
- W3029465454 hasConceptScore W3029465454C2775960820 @default.
- W3029465454 hasConceptScore W3029465454C2776694085 @default.
- W3029465454 hasConceptScore W3029465454C2777019933 @default.
- W3029465454 hasConceptScore W3029465454C2777025900 @default.
- W3029465454 hasConceptScore W3029465454C2777587049 @default.
- W3029465454 hasConceptScore W3029465454C2778239845 @default.
- W3029465454 hasConceptScore W3029465454C2778939058 @default.
- W3029465454 hasConceptScore W3029465454C2780159080 @default.
- W3029465454 hasConceptScore W3029465454C2780352672 @default.
- W3029465454 hasConceptScore W3029465454C2780394083 @default.
- W3029465454 hasConceptScore W3029465454C2781164371 @default.
- W3029465454 hasConceptScore W3029465454C55493867 @default.
- W3029465454 hasConceptScore W3029465454C62520636 @default.
- W3029465454 hasConceptScore W3029465454C71924100 @default.
- W3029465454 hasConceptScore W3029465454C91881484 @default.
- W3029465454 hasIssue "6" @default.
- W3029465454 hasLocation W30294654541 @default.
- W3029465454 hasOpenAccess W3029465454 @default.
- W3029465454 hasPrimaryLocation W30294654541 @default.
- W3029465454 hasRelatedWork W1974762321 @default.
- W3029465454 hasRelatedWork W2055281446 @default.
- W3029465454 hasRelatedWork W2078358071 @default.
- W3029465454 hasRelatedWork W2353100513 @default.
- W3029465454 hasRelatedWork W2355131347 @default.
- W3029465454 hasRelatedWork W2361368980 @default.
- W3029465454 hasRelatedWork W2368792506 @default.
- W3029465454 hasRelatedWork W2377395313 @default.
- W3029465454 hasRelatedWork W2387459698 @default.
- W3029465454 hasRelatedWork W2390334663 @default.
- W3029465454 hasRelatedWork W2410873561 @default.
- W3029465454 hasRelatedWork W2417921581 @default.
- W3029465454 hasRelatedWork W2469129484 @default.
- W3029465454 hasRelatedWork W2518682401 @default.
- W3029465454 hasRelatedWork W2945635332 @default.
- W3029465454 hasRelatedWork W3028682169 @default.
- W3029465454 hasRelatedWork W3030383742 @default.
- W3029465454 hasRelatedWork W3030874370 @default.
- W3029465454 hasRelatedWork W3030968073 @default.
- W3029465454 hasRelatedWork W3032388635 @default.
- W3029465454 hasVolume "33" @default.
- W3029465454 isParatext "false" @default.
- W3029465454 isRetracted "false" @default.
- W3029465454 magId "3029465454" @default.
- W3029465454 workType "article" @default.